Ephrins
Receptors, Eph Family
Ephrin-A5
Ephrin-B1
Receptor, EphA3
Ephrin-A2
Ephrin-B2
Receptor, EphA4
Ephrin-A4
Ephrin-A3
Receptor, EphA7
Receptor, EphB4
Receptor, EphA1
Ephrin-A1
Ephrin-B3
Receptor, EphB2
Receptor, EphB3
Receptor, EphB1
Receptor, EphA2
Receptor, EphA5
Receptor Protein-Tyrosine Kinases
Growth Cones
Syntenins
Protein Tyrosine Phosphatase, Non-Receptor Type 13
Membrane Proteins
Ligands
Signal Transduction
Body Patterning
Superior Colliculi
Neural Crest
The ephrin VAB-2/EFN-1 functions in neuronal signaling to regulate epidermal morphogenesis in C. elegans. (1/216)
The Eph receptor VAB-1 is required in neurons for epidermal morphogenesis during C. elegans embryogenesis. Two models were proposed for the non-autonomous role of VAB-1: neuronal VAB-1 might signal directly to epidermis, or VAB-1 signaling between neurons might be required for epidermal development. We show that the ephrin VAB-2 (also known as EFN-1) is a ligand for VAB-1 and can function in neurons to regulate epidermal morphogenesis. In the absence of VAB-1 signaling, ephrin-expressing neurons are disorganized. vab-2/efn-1 mutations synergize with vab-1 kinase alleles, suggesting that VAB-2/EFN-1 may partly function in a kinase-independent VAB-1 pathway. Our data indicate that ephrin signaling between neurons is required nonautonomously for epidermal morphogenesis in C. elegans. (+info)The C. elegans LAR-like receptor tyrosine phosphatase PTP-3 and the VAB-1 Eph receptor tyrosine kinase have partly redundant functions in morphogenesis. (2/216)
Receptor-like protein-tyrosine phosphatases (RPTPs) form a diverse family of cell surface molecules whose functions remain poorly understood. The LAR subfamily of RPTPs has been implicated in axon guidance and neural development. Here we report the molecular and genetic analysis of the C. elegans LAR subfamily member PTP-3. PTP-3 isoforms are expressed in many tissues in early embryogenesis, and later become localized to neuronal processes and to epithelial adherens junctions. Loss of function in ptp-3 causes low-penetrance defects in gastrulation and epidermal development similar to those of VAB-1 Eph receptor tyrosine kinase mutants. Loss of function in ptp-3 synergistically enhances phenotypes of mutations in the C. elegans Eph receptor VAB-1 and a subset of its ephrin ligands, but does not show specific interactions with several other RTKs or morphogenetic mutants. The genetic interaction of vab-1 and ptp-3 suggests that LAR-like RPTPs and Eph receptors have related and partly redundant functions in C. elegans morphogenesis. (+info)The role of the Eph-ephrin signalling system in the regulation of developmental patterning. (3/216)
The Eph and ephrin system, consisting of fourteen Eph receptor tyrosine kinase proteins and nine ephrin membrane proteins in vertebrates, has been implicated in the regulation of many critical events during development. Binding of cell surface Eph and ephrin proteins results in bi-directional signals, which regulate the cytoskeletal, adhesive and motile properties of the interacting cells. Through these signals Eph and ephrin proteins are involved in early embryonic cell movements, which establish the germ layers, cell movements involved in formation of tissue boundaries and the pathfinding of axons. This review focuses on two vertebrate models, the zebrafish and mouse, in which experimental perturbation of Eph and/or ephrin expression in vivo have provided important insights into the role and functioning of the Eph/ephrin system. (+info)Axon guidance receptors direct growth cone pathfinding: rivalry at the leading edge. (4/216)
One of the earliest steps in the development of the central and peripheral nervous systems is the initiation of axon outgrowth from newly born neurons. Nascent axons then navigate towards their specific targets to establish the intricate network of axon projections found within the mature central nervous system. In doing so, the projecting axons must continually reassess their spatial environment and accurately select the correct pathways among the maze of possible routes. A variety of molecular navigational systems governing axon pathfinding have now been identified. Understanding how these individual molecular guidance systems operate at the level of a single axon, and, how these different systems work in concert to initiate and steer axonal migration is a major goal in developmental neurobiology. (+info)An ephrin mimetic peptide that selectively targets the EphA2 receptor. (5/216)
Eph receptor tyrosine kinases represent promising disease targets because they are differentially expressed in pathologic versus normal tissues. The EphA2 receptor is up-regulated in transformed cells and tumor vasculature where it likely contributes to cancer pathogenesis. To exploit EphA2 as a therapeutic target, we used phage display to identify two related peptides that bind selectively to EphA2 with high affinity (submicromolar K(D) values). The peptides target the ligand-binding domain of EphA2 and compete with ephrin ligands for binding. Remarkably, one of the peptides has ephrin-like activity in that it stimulates EphA2 tyrosine phosphorylation and signaling. Furthermore, this peptide can deliver phage particles to endothelial and tumor cells expressing EphA2. In contrast, peptides corresponding to receptor-interacting portions of ephrin ligands bind weakly and promiscuously to many Eph receptors. Bioactive ephrin mimetic peptides could be used to selectively deliver agents to Eph receptor-expressing tissues and modify Eph signaling in therapies for cancer, pathological angiogenesis, and nerve regeneration. (+info)The divergent C. elegans ephrin EFN-4 functions inembryonic morphogenesis in a pathway independent of the VAB-1 Eph receptor. (6/216)
The C. elegans genome encodes a single Eph receptor tyrosine kinase, VAB-1, which functions in neurons to control epidermal morphogenesis. Four members of the ephrin family of ligands for Eph receptors have been identified in C. elegans. Three ephrins (EFN-1/VAB-2, EFN-2 and EFN-3) have been previously shown to function in VAB-1 signaling. We show that mutations in the gene mab-26 affect the fourth C. elegans ephrin, EFN-4. We show that efn-4 also functions in embryonic morphogenesis, and that it is expressed in the developing nervous system. Interestingly, efn-4 mutations display synergistic interactions with mutations in the VAB-1 receptor and in the EFN-1 ephrin, indicating that EFN-4 may function independently of the VAB-1 Eph receptor in morphogenesis. Mutations in the LAR-like receptor tyrosine phosphatase PTP-3 and in the Semaphorin-2A homolog MAB-20 disrupt embryonic neural morphogenesis. efn-4 mutations synergize with ptp-3 mutations, but not with mab-20 mutations, suggesting that EFN-4 and Semaphorin signaling could function in a common pathway or in opposing pathways in C. elegans embryogenesis. (+info)Association of Dishevelled with Eph tyrosine kinase receptor and ephrin mediates cell repulsion. (7/216)
Eph tyrosine kinase receptors and their membrane-bound ligands, ephrins, are presumed to regulate cell-cell interactions. The major consequence of bidirectional activation of Eph receptors and ephrin ligands is cell repulsion. In this study, we discovered that Xenopus Dishevelled (Xdsh) forms a complex with Eph receptors and ephrin-B ligands and mediates the cell repulsion induced by Eph and ephrin. In vitro re-aggregation assays with Xenopus animal cap explants revealed that co-expression of a dominant-negative mutant of Xdsh affected the sorting of cells expressing EphB2 and those expressing ephrin-B1. Co-expression of Xdsh induced the activation of RhoA and Rho kinase in the EphB2-overexpressed cells and in the cells expressing EphB2-stimulated ephrin-B1. Therefore, Xdsh mediates both forward and reverse signaling of EphB2 and ephrin-B1, leading to the activation of RhoA and its effector protein Rho kinase. The inhibition of RhoA activity in animal caps significantly prevents the EphB2- and ephrin-B1-mediated cell sorting. We propose that Xdsh, which is expressed in various tissues, is involved in EphB and ephrin-B signaling related to regulation of cell repulsion via modification of RhoA activity. (+info)Molecular control of arterial-venous blood vessel identity. (8/216)
Recent research has demonstrated that not only haemodynamic factors but also genetic programmes control arterial-venous cell fate and blood vessel identity. The identification of arteries and veins was previously based solely on morphological criteria and is now greatly facilitated by specific molecular markers. Moreover, signalling pathways controlling the arterial-venous decision during embryonic development have been outlined for the first time. This review gives an up-to-date overview of differentially expressed genes and the regulatory processes leading to the differentiation of arteries and veins. (+info)Ephrins are a family of membrane-bound proteins that play crucial roles in various biological processes, including cell migration, axon guidance, and tissue boundary formation during embryonic development. They interact with Eph receptors, which are tyrosine kinase receptors found on the surface of neighboring cells. This interaction results in bidirectional signaling between the two cells, affecting their behaviors and influencing the organization of tissues and organs.
There are two main types of ephrins: Ephrin-A (also known as GPI-anchored ephrins) and Ephrin-B (transmembrane ephrins). Ephrin-A proteins are attached to the cell membrane through a glycosylphosphatidylinositol (GPI) anchor, while Ephrin-B proteins have a transmembrane domain and a cytoplasmic tail. Both types of ephrins interact with Eph receptors, leading to the initiation of intracellular signaling cascades that regulate various cellular responses.
Dysregulation of ephrin/Eph receptor interactions has been implicated in several human diseases, including cancer, where they can contribute to tumor growth, progression, and metastasis. Therefore, understanding the functions and regulation of ephrins and their receptors is essential for developing novel therapeutic strategies to treat various diseases.
Eph family receptors are a group of tyrosine kinase receptors that play crucial roles in the development and function of the nervous system, as well as in other tissues. They are named after the first discovered member of this family, EPH (Erythropoietin-Producing Human Hepatocellular carcinoma) receptor.
These receptors are divided into two subfamilies: EphA and EphB, based on their binding preferences for ephrin ligands. Ephrins are membrane-bound proteins that can be either GPI-anchored (ephrin-A) or transmembrane (ephrin-B), and they interact with Eph receptors in a bidirectional manner, activating both forward signaling in the receptor-expressing cell and reverse signaling in the ephrin-expressing cell.
Eph receptors and ephrins are essential for axon guidance, topographic mapping, and synaptic plasticity during neural development. They also participate in various processes in adult tissues, such as angiogenesis, tumorigenesis, and immune responses. Dysregulation of Eph family receptors has been implicated in several diseases, including cancer, neurological disorders, and vascular diseases.
Ephrin-A5 is a type of protein that belongs to the ephrin family. Ephrins are membrane-bound proteins that interact with Eph receptors, which are tyrosine kinase receptors found on the surface of cells. The interaction between ephrins and Eph receptors plays a crucial role in the development and function of the nervous system, including axon guidance, cell migration, and synaptic plasticity.
Ephrin-A5 is specifically classified as a glycosylphosphatidylinositol (GPI)-anchored protein, which means it is attached to the outer layer of the cell membrane through a GPI anchor. It is primarily expressed in various tissues, including the brain, heart, and lungs.
In the nervous system, Ephrin-A5 and its receptor, EphA4, are involved in repulsive guidance cues that help to establish proper neuronal connections during development. Dysregulation of this interaction has been implicated in several neurological disorders, such as spinal cord injuries, Alzheimer's disease, and schizophrenia.
Ephrin-B1 is a type of protein that belongs to the ephrin family and is involved in cell signaling, specifically in the process known as cell-cell communication. It is a transmembrane protein, which means it spans the membrane of the cell and has a portion that faces the outside of the cell (the extracellular domain) and a portion that faces the inside of the cell (the intracellular domain).
Ephrin-B1 binds to Eph receptors, which are tyrosine kinase receptors found on the surface of neighboring cells. This binding results in the initiation of a signaling cascade that can influence various cellular processes, including cell migration, adhesion, and proliferation.
Ephrin-B1 is widely expressed in various tissues throughout the body, including the nervous system, where it plays important roles in the development and function of the brain. Mutations in the gene that encodes ephrin-B1 have been associated with certain neurological disorders, such as intellectual disability and epilepsy.
EphA3 is a type of receptor tyrosine kinase (RTK) that belongs to the Eph family of receptors. It is a transmembrane protein involved in cell-cell communication and signal transduction. The EphA3 receptor specifically binds to ephrin-A5, its ligand, leading to various intracellular signaling events that regulate cell behavior, including cell migration, adhesion, and differentiation.
EphA3 is widely expressed in various tissues, including the nervous system, hematopoietic cells, and epithelial cells. In the nervous system, EphA3 plays a crucial role in axon guidance and neuronal positioning during development. In hematopoietic cells, it has been implicated in the regulation of immune cell function and the development of certain types of leukemia.
Mutations or aberrant expression of EphA3 have been associated with several diseases, including cancer, making it a potential target for therapeutic intervention.
Ephrin-A2 is a type of protein that belongs to the ephrin family. It is a membrane-bound ligand for Eph receptors, which are tyrosine kinase receptors located on the cell surface. Ephrin-A2 and Eph receptors play critical roles in various biological processes, including axon guidance, tissue boundary formation, and tumorigenesis.
Ephrin-A2 is encoded by the EFNB2 gene and is expressed on the cell membrane as a glycosylphosphatidylinositol (GPI)-anchored protein. It can interact with several Eph receptors, including EphA3, EphA4, EphA5, and EphA7, leading to bidirectional signaling that regulates cell-cell interactions and communication.
In the nervous system, ephrin-A2 and its receptors are essential for the development and maintenance of neural circuits. They help to establish precise connections between neurons by mediating repulsive interactions that guide axon growth and fasciculation. Additionally, ephrin-A2 has been implicated in various pathological conditions, such as cancer, where it can contribute to tumor progression and metastasis.
Ephrin-B2 is a type of protein that belongs to the ephrin family and is primarily involved in the development and function of the nervous system. It is a membrane-bound ligand for Eph receptor tyrosine kinases, and their interactions play crucial roles in cell-cell communication during embryogenesis and adult tissue homeostasis.
Ephrin-B2 is specifically a glycosylphosphatidylinositol (GPI)-anchored protein that is expressed on the cell membrane of various cell types, including endothelial cells, neurons, and some immune cells. Its interactions with Eph receptors, which are transmembrane proteins, lead to bidirectional signaling across the contacting cell membranes. This process regulates various aspects of cell behavior, such as adhesion, migration, repulsion, and proliferation.
In the context of the cardiovascular system, ephrin-B2 is essential for the development and maintenance of blood vessels. It is involved in the formation of arterial-venous boundaries, vascular branching, and remodeling. Mutations or dysregulation of ephrin-B2 have been implicated in various diseases, including cancer, where it can contribute to tumor angiogenesis and metastasis.
EphA4 is a type of receptor tyrosine kinase that belongs to the Eph (Erythropoietin-producing hepatocellular) family of receptors. It is a transmembrane protein found on the surface of various types of cells, including neurons and glial cells in the nervous system.
EphA4 receptors play critical roles in several biological processes, such as cell migration, axon guidance, and synaptic plasticity during development and throughout adulthood. They interact with ephrin proteins, which are ligands (molecules that bind to receptors) found on adjacent cells. The interaction between EphA4 and ephrins triggers a cascade of intracellular signaling events that ultimately influence cell behavior.
In summary, EphA4 is a type of receptor involved in cell-cell communication, particularly during the development and functioning of the nervous system. Its dysfunction has been implicated in several neurological disorders, such as spinal cord injuries, Alzheimer's disease, and various forms of cancer.
Ephrin-A4 is a type of protein that belongs to the ephrin family. Ephrins are membrane-bound proteins that play crucial roles in various biological processes, including cell signaling and communication during development. Specifically, Ephrin-A4 is a ligand for Eph receptors, which are tyrosine kinase receptors located on the cell membrane.
Ephrin-A4 is composed of a glycosylphosphatidylinositol (GPI) anchor that attaches it to the cell membrane and an extracellular domain that interacts with Eph receptors. When Ephrin-A4 binds to an Eph receptor on a neighboring cell, it triggers a cascade of intracellular signaling events that can regulate various cellular processes, such as cell adhesion, migration, and proliferation.
In the medical field, Ephrin-A4 has been studied in the context of various diseases, including cancer. For example, abnormal expression of Ephrin-A4 has been observed in several types of tumors, and it has been suggested to play a role in tumor progression and metastasis. However, more research is needed to fully understand the functional significance of Ephrin-A4 in health and disease.
Ephrin-A3 is a type of protein that belongs to the ephrin family. Ephrins are membrane-bound proteins that play crucial roles in various biological processes, including cell signaling and communication during development. Specifically, Ephrin-A3 binds to Eph receptors, which are tyrosine kinase receptors found on the surface of neighboring cells. This binding leads to bidirectional signals that regulate cell adhesion, repulsion, and migration, thereby helping to establish proper tissue and organ architecture during development. Additionally, Ephrin-A3 has been implicated in various physiological and pathological processes, such as angiogenesis, neurogenesis, and cancer.
EphA7 is a type of receptor that belongs to the EPH receptor tyrosine kinase family. These receptors are involved in intracellular signaling and play crucial roles in various biological processes, including cell growth, differentiation, and migration.
EphA7 receptors are specifically activated by ephrin-A ligands, which are membrane-bound proteins expressed on adjacent cells. When an ephrin-A ligand binds to an EphA7 receptor, it triggers a cascade of intracellular signaling events that can affect various cellular functions.
EphA7 receptors have been implicated in several physiological and pathological processes, including nervous system development, angiogenesis, and cancer. In the nervous system, EphA7 receptors help to establish connections between neurons and guide their migration during development. In cancer, abnormal expression or activation of EphA7 receptors has been linked to tumor growth, progression, and metastasis.
It's worth noting that while I strive to provide accurate and up-to-date information, medical definitions can be complex and nuanced. Therefore, it may be helpful to consult authoritative medical resources or speak with a healthcare professional for more detailed information on this topic.
EphB4 is a type of receptor tyrosine kinase (RTK) that belongs to the Eph receptor family. These receptors are involved in cell-cell communication during development and tissue homeostasis. Specifically, EphB4 is a membrane-bound protein that interacts with its ligand, ephrin-B2, which is also a transmembrane protein, to mediate bidirectional signaling between neighboring cells.
The binding of ephrin-B2 to EphB4 triggers a variety of intracellular signaling events that regulate various cellular processes, including cell migration, adhesion, and repulsion. In the context of the cardiovascular system, EphB4 plays important roles in vascular development, angiogenesis, and arterial-venous specification.
Mutations or dysregulation of EphB4 have been implicated in various pathological conditions, such as cancer, atherosclerosis, and neurological disorders. Therefore, understanding the function and regulation of EphB4 has important implications for the development of novel therapeutic strategies for these diseases.
EphA1 is a type of receptor tyrosine kinase (RTK) that belongs to the Eph family of receptors. It is a single-pass transmembrane protein that contains an extracellular domain with a binding site for its ligand, ephrin-A5, and an intracellular domain with tyrosine kinase activity.
EphA1 receptors are involved in various biological processes, including cell migration, axon guidance, and tissue boundary formation during embryonic development. They also play a role in angiogenesis, neuroprotection, and tumorigenesis in adults.
The binding of ephrin-A5 to EphA1 receptors triggers bidirectional signaling, affecting both the receptor-expressing cell and the ephrin-presenting cell. This interaction can lead to repulsion, adhesion, or collapse of the growth cone, depending on the context and the specific Eph/ephrin pair involved.
Mutations in EphA1 have been associated with various diseases, including cancer, neurodevelopmental disorders, and cardiovascular disease.
Ephrin-A1 is a type of protein that belongs to the ephrin family. It is a membrane-bound ligand for Eph receptors, which are tyrosine kinase receptors located on the cell surface. Ephrin-A1 and its receptors play critical roles in various biological processes, including cell migration, axon guidance, and tissue boundary formation during embryonic development. Ephrin-A1 is also involved in angiogenesis, tumorigenesis, and metastasis in cancer. It is encoded by the EFNAs gene in humans.
Ephrin-B3 is a type of protein that belongs to the ephrin family and is involved in cell signaling, particularly during the development and functioning of the nervous system. It is a transmembrane protein, which means it spans the membrane of the cell and has a domain outside the cell and a domain inside the cell.
Ephrin-B3 interacts with Eph receptors on neighboring cells to initiate bidirectional signaling, which means that both the cells that express ephrin-B3 and the cells that express the Eph receptor are affected by this interaction. This signaling is important for various processes such as axon guidance, cell migration, and tissue boundaries formation during development. In addition, ephrin-B3 has been implicated in the regulation of synaptic plasticity and vascular remodeling in adults.
Mutations in the gene that encodes ephrin-B3 have been associated with certain neurological disorders, such as intellectual disability and epilepsy.
EphB2 is a type of receptor tyrosine kinase (RTK) that belongs to the Eph family of receptors. These receptors are involved in bidirectional communication between cells and are important in the development and function of the nervous system. Specifically, EphB2 receptors are expressed on the surface of certain types of neurons and bind to ephrin-B ligands on nearby cells. This binding triggers a cascade of intracellular signaling events that can regulate various cellular processes, including cell migration, adhesion, and axon guidance.
EphB2 receptors have also been implicated in the pathology of several diseases, including cancer. For example, abnormal activation of EphB2 has been linked to tumor growth, progression, and metastasis in certain types of cancer. Therefore, EphB2 is an important target for the development of new therapies for cancer and other diseases.
EphB3 is a type of receptor tyrosine kinase that belongs to the Eph family of receptors. It is a transmembrane protein that plays a crucial role in cell signaling and communication, particularly during embryonic development and tissue organization. The EphB3 receptor binds to ephrin-B ligands, which are also transmembrane proteins expressed on neighboring cells.
The binding of ephrin-B to EphB3 initiates a bidirectional signaling process that regulates various cellular processes such as cell adhesion, migration, and repulsion. This interaction is important for the formation of boundaries between different tissues, axon guidance, and synaptic plasticity in the nervous system.
Mutations in the EphB3 gene have been associated with several human diseases, including cancer, immune disorders, and neurological conditions. Therefore, understanding the function and regulation of EphB3 receptors is essential for developing novel therapeutic strategies to treat these diseases.
EphB1 is a type of receptor tyrosine kinase (RTK) that belongs to the Eph family of receptors. It is a single-pass transmembrane protein that contains an extracellular domain with a binding site for its ligand, ephrin-Bs, and an intracellular domain with tyrosine kinase activity.
EphB1 receptors are primarily expressed in the nervous system, where they play important roles in various developmental processes, including axon guidance, neuronal migration, and synaptic plasticity. They also have been implicated in tumorigenesis and cancer progression, as well as in the regulation of immune responses.
The binding of ephrin-Bs to EphB1 receptors triggers a variety of intracellular signaling pathways that can lead to both forward and reverse signaling. Forward signaling occurs when the activated EphB1 receptor phosphorylates downstream effector proteins, leading to changes in cell behavior such as repulsion or adhesion. Reverse signaling occurs when ephrin-Bs, which are also transmembrane proteins, activate their own intracellular signaling pathways upon binding to EphB1 receptors.
Overall, the EphB1 receptor is a crucial component of the Eph/ephrin signaling system that plays important roles in various biological processes and has potential implications for disease treatment and diagnosis.
EphA2 is a type of receptor tyrosine kinase (RTK) that belongs to the Eph (Erythropoietin-producing hepatocellular) family of receptors. It is a transmembrane protein found on the surface of many types of cells, including epithelial, endothelial, and cancer cells.
EphA2 receptors play critical roles in various biological processes such as cell growth, survival, migration, and angiogenesis. They interact with their ligands, called ephrins, which are also transmembrane proteins expressed on adjacent cells. The interaction between EphA2 and ephrins triggers bidirectional signaling that can regulate the adhesion, repulsion, or movement of cells in response to contact with other cells.
In cancer biology, EphA2 receptors have been implicated in tumor progression and metastasis. Overexpression of EphA2 has been observed in various types of human cancers, including breast, lung, prostate, ovarian, and colon cancer. High levels of EphA2 are often associated with poor clinical outcomes, making it an attractive therapeutic target for cancer treatment.
EphA5 is a type of receptor tyrosine kinase that belongs to the Eph receptor family. Eph receptors are the largest subfamily of receptor tyrosine kinases and play critical roles in various biological processes, including cell migration, axon guidance, and tissue boundary formation during embryonic development.
EphA5 receptor specifically binds to ephrin-A5 ligand, which is a member of the ephrin family of membrane-bound proteins. The binding of ephrin-A5 to EphA5 triggers bidirectional signaling, meaning that both the receptor and the ligand can transmit signals into their respective cells. This interaction leads to various cellular responses, such as changes in cytoskeletal organization, cell adhesion, and intracellular signaling pathways.
EphA5 has been implicated in several physiological and pathological processes, including neural development, vascular remodeling, tumor angiogenesis, and cancer metastasis. Mutations in the EPHA5 gene have been associated with various human diseases, such as intellectual disability, epilepsy, and congenital heart defects.
Fetal proteins are a type of proteins that are produced by the fetus during pregnancy and can be detected in various biological samples, such as amniotic fluid or maternal blood. These proteins can provide valuable information about the health and development of the fetus. One commonly studied fetal protein is human chorionic gonadotropin (hCG), which is produced by the placenta and can be used as a marker for pregnancy and to detect potential complications, such as Down syndrome or spinal cord defects. Other examples of fetal proteins include alpha-fetoprotein (AFP) and human placental lactogen (hPL).
Receptor Protein-Tyrosine Kinases (RTKs) are a type of transmembrane receptors found on the cell surface that play a crucial role in signal transduction and regulation of various cellular processes, including cell growth, differentiation, metabolism, and survival. They are called "tyrosine kinases" because they possess an intrinsic enzymatic activity that catalyzes the transfer of a phosphate group from ATP to tyrosine residues on target proteins, thereby modulating their function.
RTKs are composed of three main domains: an extracellular domain that binds to specific ligands (growth factors, hormones, or cytokines), a transmembrane domain that spans the cell membrane, and an intracellular domain with tyrosine kinase activity. Upon ligand binding, RTKs undergo conformational changes that lead to their dimerization or oligomerization, which in turn activates their tyrosine kinase activity. Activated RTKs then phosphorylate specific tyrosine residues on downstream signaling proteins, initiating a cascade of intracellular signaling events that ultimately result in the appropriate cellular response.
Dysregulation of RTK signaling has been implicated in various human diseases, including cancer, diabetes, and developmental disorders. As such, RTKs are important targets for therapeutic intervention in these conditions.
Growth cones are specialized structures found at the tips of growing neurites (axons and dendrites) during the development and regeneration of the nervous system. They were first described by Santiago Ramón y Cajal in the late 19th century. Growth cones play a crucial role in the process of neurogenesis, guiding the extension and pathfinding of axons to their appropriate targets through a dynamic interplay with environmental cues. These cues include various guidance molecules, such as netrins, semaphorins, ephrins, and slits, which bind to receptors on the growth cone membrane and trigger intracellular signaling cascades that ultimately determine the direction of axonal outgrowth.
Morphologically, a growth cone consists of three main parts: the central domain (or "C-domain"), the peripheral domain (or "P-domain"), and the transition zone connecting them. The C-domain contains microtubules and neurofilaments, which provide structural support and transport materials to the growing neurite. The P-domain is rich in actin filaments and contains numerous membrane protrusions called filopodia and lamellipodia, which explore the environment for guidance cues and facilitate motility.
The dynamic behavior of growth cones allows them to navigate complex environments, make decisions at choice points, and ultimately form precise neural circuits during development. Understanding the mechanisms that regulate growth cone function is essential for developing strategies to promote neural repair and regeneration in various neurological disorders and injuries.
Syntenins are a group of proteins that play a role in the organization and maintenance of the cell membrane. They are characterized by the presence of a conserved N-terminal domain called the SAP (SAF-A/B, Acinus, and PIAS) domain, which mediates protein-protein interactions, and a C-terminal domain that contains binding sites for various proteins involved in the organization of the cytoskeleton and cell adhesion.
Syntenins are thought to function as scaffolding proteins, helping to link together different components of the cell membrane and the cytoskeleton. They have been implicated in a variety of cellular processes, including the formation and maintenance of cell-cell junctions, the regulation of cell shape and motility, and the organization of signaling complexes at the cell membrane.
There are three known syntenin isoforms, syntenin-1, syntenin-2, and syntenin-3, which are encoded by different genes but share a similar overall structure. Syntenin-1 is the most well-studied isoform and is widely expressed in various tissues. Mutations in the syntenin-1 gene have been associated with certain neurological disorders, highlighting its importance in normal brain function.
An axon is a long, slender extension of a neuron (a type of nerve cell) that conducts electrical impulses (nerve impulses) away from the cell body to target cells, such as other neurons or muscle cells. Axons can vary in length from a few micrometers to over a meter long and are typically surrounded by a myelin sheath, which helps to insulate and protect the axon and allows for faster transmission of nerve impulses.
Axons play a critical role in the functioning of the nervous system, as they provide the means by which neurons communicate with one another and with other cells in the body. Damage to axons can result in serious neurological problems, such as those seen in spinal cord injuries or neurodegenerative diseases like multiple sclerosis.
Protein Tyrosine Phosphatase, Non-Receptor Type 13 (PTPN13), also known as PTP Delta or PTPD, is a protein tyrosine phosphatase enzyme that plays a crucial role in regulating various cellular processes, including cell growth, differentiation, and migration. It is a non-receptor type phosphatase, meaning it does not have a transmembrane domain and is localized in the cytoplasm.
PTPN13 contains several functional domains, including a catalytic domain that dephosphorylates tyrosine residues on target proteins, a protein-protein interaction domain, and a focal adhesion targeting (FAT) domain that localizes the enzyme to focal adhesions, which are sites of cell-matrix contact.
PTPN13 has been shown to interact with and dephosphorylate several signaling molecules, including receptor tyrosine kinases, adaptor proteins, and small GTPases, thereby regulating various downstream signaling pathways involved in cell survival, proliferation, and migration. Dysregulation of PTPN13 has been implicated in the development and progression of several diseases, including cancer, cardiovascular disease, and neurological disorders.
Membrane proteins are a type of protein that are embedded in the lipid bilayer of biological membranes, such as the plasma membrane of cells or the inner membrane of mitochondria. These proteins play crucial roles in various cellular processes, including:
1. Cell-cell recognition and signaling
2. Transport of molecules across the membrane (selective permeability)
3. Enzymatic reactions at the membrane surface
4. Energy transduction and conversion
5. Mechanosensation and signal transduction
Membrane proteins can be classified into two main categories: integral membrane proteins, which are permanently associated with the lipid bilayer, and peripheral membrane proteins, which are temporarily or loosely attached to the membrane surface. Integral membrane proteins can further be divided into three subcategories based on their topology:
1. Transmembrane proteins, which span the entire width of the lipid bilayer with one or more alpha-helices or beta-barrels.
2. Lipid-anchored proteins, which are covalently attached to lipids in the membrane via a glycosylphosphatidylinositol (GPI) anchor or other lipid modifications.
3. Monotopic proteins, which are partially embedded in the membrane and have one or more domains exposed to either side of the bilayer.
Membrane proteins are essential for maintaining cellular homeostasis and are targets for various therapeutic interventions, including drug development and gene therapy. However, their structural complexity and hydrophobicity make them challenging to study using traditional biochemical methods, requiring specialized techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and single-particle cryo-electron microscopy (cryo-EM).
A ligand, in the context of biochemistry and medicine, is a molecule that binds to a specific site on a protein or a larger biomolecule, such as an enzyme or a receptor. This binding interaction can modify the function or activity of the target protein, either activating it or inhibiting it. Ligands can be small molecules, like hormones or neurotransmitters, or larger structures, like antibodies. The study of ligand-protein interactions is crucial for understanding cellular processes and developing drugs, as many therapeutic compounds function by binding to specific targets within the body.
Signal transduction is the process by which a cell converts an extracellular signal, such as a hormone or neurotransmitter, into an intracellular response. This involves a series of molecular events that transmit the signal from the cell surface to the interior of the cell, ultimately resulting in changes in gene expression, protein activity, or metabolism.
The process typically begins with the binding of the extracellular signal to a receptor located on the cell membrane. This binding event activates the receptor, which then triggers a cascade of intracellular signaling molecules, such as second messengers, protein kinases, and ion channels. These molecules amplify and propagate the signal, ultimately leading to the activation or inhibition of specific cellular responses.
Signal transduction pathways are highly regulated and can be modulated by various factors, including other signaling molecules, post-translational modifications, and feedback mechanisms. Dysregulation of these pathways has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.
"Body patterning" is a general term that refers to the process of forming and organizing various tissues and structures into specific patterns during embryonic development. This complex process involves a variety of molecular mechanisms, including gene expression, cell signaling, and cell-cell interactions. It results in the creation of distinct body regions, such as the head, trunk, and limbs, as well as the organization of internal organs and systems.
In medical terminology, "body patterning" may refer to specific developmental processes or abnormalities related to embryonic development. For example, in genetic disorders such as Poland syndrome or Holt-Oram syndrome, mutations in certain genes can lead to abnormal body patterning, resulting in the absence or underdevelopment of certain muscles, bones, or other structures.
It's important to note that "body patterning" is not a formal medical term with a specific definition, but rather a general concept used in developmental biology and genetics.
The superior colliculi are a pair of prominent eminences located on the dorsal surface of the midbrain, forming part of the tectum or roof of the midbrain. They play a crucial role in the integration and coordination of visual, auditory, and somatosensory information for the purpose of directing spatial attention and ocular movements. Essentially, they are involved in the reflexive orienting of the head and eyes towards novel or significant stimuli in the environment.
In a more detailed medical definition, the superior colliculi are two rounded, convex mounds of gray matter that are situated on the roof of the midbrain, specifically at the level of the rostral mesencephalic tegmentum. Each superior colliculus has a stratified laminated structure, consisting of several layers that process different types of sensory information and control specific motor outputs.
The superficial layers of the superior colliculi primarily receive and process visual input from the retina, lateral geniculate nucleus, and other visual areas in the brain. These layers are responsible for generating spatial maps of the visual field, which allow for the localization and identification of visual stimuli.
The intermediate and deep layers of the superior colliculi receive and process auditory and somatosensory information from various sources, including the inferior colliculus, medial geniculate nucleus, and ventral posterior nucleus of the thalamus. These layers are involved in the localization and identification of auditory and tactile stimuli, as well as the coordination of head and eye movements towards these stimuli.
The superior colliculi also contain a population of neurons called "motor command neurons" that directly control the muscles responsible for orienting the eyes, head, and body towards novel or significant sensory events. These motor command neurons are activated in response to specific patterns of activity in the sensory layers of the superior colliculus, allowing for the rapid and automatic orientation of attention and gaze towards salient stimuli.
In summary, the superior colliculi are a pair of structures located on the dorsal surface of the midbrain that play a critical role in the integration and coordination of visual, auditory, and somatosensory information for the purpose of orienting attention and gaze towards salient stimuli. They contain sensory layers that generate spatial maps of the environment, as well as motor command neurons that directly control the muscles responsible for orienting the eyes, head, and body.
The neural crest is a transient, multipotent embryonic cell population that originates from the ectoderm (outermost layer) of the developing neural tube (precursor to the central nervous system). These cells undergo an epithelial-to-mesenchymal transition and migrate throughout the embryo, giving rise to a diverse array of cell types and structures.
Neural crest cells differentiate into various tissues, including:
1. Peripheral nervous system (PNS) components: sensory neurons, sympathetic and parasympathetic ganglia, and glial cells (e.g., Schwann cells).
2. Facial bones and cartilage, as well as connective tissue of the skull.
3. Melanocytes, which are pigment-producing cells in the skin.
4. Smooth muscle cells in major blood vessels, heart, gastrointestinal tract, and other organs.
5. Secretory cells in endocrine glands (e.g., chromaffin cells of the adrenal medulla).
6. Parts of the eye, such as the cornea and iris stroma.
7. Dental tissues, including dentin, cementum, and dental pulp.
Due to their wide-ranging contributions to various tissues and organs, neural crest cells play a crucial role in embryonic development and organogenesis. Abnormalities in neural crest cell migration or differentiation can lead to several congenital disorders, such as neurocristopathies.